We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+18.92%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$598M
AUM Growth
+$132M
Cap. Flow
+$140M
Cap. Flow %
23.32%
Top 10 Hldgs %
44.39%
Holding
102
New
38
Increased
16
Reduced
12
Closed
21

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$24.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.2M
3
MSFT icon
Microsoft
MSFT
+$13.9M
4
NTR icon
Nutrien
NTR
+$11.2M
5
AMZN icon
Amazon
AMZN
+$8.28M

Top Sells

Rank Stock Value
1
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$10.9M
2
ALBO
Albireo Pharma Inc
ALBO
+$10M
3
AZN icon
AstraZeneca
AZN
+$7.74M
4
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$6.51M
5
KROS icon
Keros Therapeutics
KROS
+$6.5M

Sector Composition

Rank Sector Weight
1 Healthcare 59.53%
2 Technology 8.91%
3 Materials 1.8%
4 Consumer Discretionary 1.48%
5 Utilities 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMTXW
76
DELISTED
Immatics N.V. Warrants
IMTXW
$144K 0.02%
100,000
– –
BGMS
77
Bio Green Med Solution Inc
BGMS
$4.91M
$143K 0.02%
69
– –
ARBE icon
78
Arbe Robotics
ARBE
$80.3M
$138K 0.02%
43,165
– –
MRSN
79
DELISTED
Mersana Therapeutics
MRSN
$43.7K 0.01%
+425
New +$59.7K
AMAT icon
80
Applied Materials
AMAT
$403B
– –
-8,499
Closed -$828K
APLS
81
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-60,000
Closed -$3.1M
AUTL
82
Autolus Therapeutics
AUTL
$397M
– –
-500,000
Closed -$950K
BCAB icon
83
BioAtla
BCAB
$5.46M
– –
-3,732
Closed -$1.54M
DRS icon
84
Leonardo DRS
DRS
$12.3B
– –
-335,557
Closed -$4.29M
ETNB
85
CALL
DELISTED
89bio
ETNB
– –
-3,600
Closed -$45.8K
ETNB
86
DELISTED
89bio
ETNB
– –
-180,600
Closed -$2.3M
FIVN icon
87
FIVE9
FIVN
$2.11B
– –
-95,000
Closed -$6.45M
GNRC icon
88
Generac Holdings
GNRC
$11.6B
– –
-50,000
Closed -$5.03M
MGIC
89
DELISTED
Magic Software Enterprises
MGIC
– –
-21,981
Closed -$352K
TEAD
90
Teads Holding Co
TEAD
$68.7M
– –
-12,148
Closed -$44K
QQQ icon
91
CALL
Invesco QQQ Trust
QQQ
$453B
– –
-231,000
Closed -$61.5M
QQQ icon
92
PUT
Invesco QQQ Trust
QQQ
$453B
– –
-210,000
Closed -$55.9M
STOK icon
93
Stoke Therapeutics
STOK
$1.8B
– –
-188,640
Closed -$1.74M
TBLA icon
94
Taboola.com
TBLA
$1.37B
– –
-120,000
Closed -$370K
TSEM icon
95
PUT
Tower Semiconductor
TSEM
$24.8B
– –
-161,600
Closed -$6.98M
XBI icon
96
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-70,000
Closed -$5.81M
CNCE
97
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-1,002,783
Closed -$5.86M
ALBO
98
DELISTED
Albireo Pharma Inc
ALBO
– –
-463,828
Closed -$10M
CINC
99
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-529,640
Closed -$6.51M
1 2 3
4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sphera Funds Management held 102 positions worth $598M, up 28% from $466M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sphera Funds Management deployed $140M of net new capital in Q1 2023, opening 38 new positions and adding to 16 existing holdings. Its largest new stake was Nice: 115,482 shares worth $26.4M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 60% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Crinetics Pharmaceuticals, an estimated $10.9M trimmed.

  • Sphera Funds Management's largest Q1 2023 buy was Nice: 115,482 shares worth $26.4M.
  • Sphera Funds Management added most to Biogen in Q1 2023, an estimated $7.19M increase.
  • Sphera Funds Management's biggest Q1 2023 reduction was Crinetics Pharmaceuticals, cutting an estimated $10.9M.
  • Sphera Funds Management fully exited Albireo Pharma Inc in Q1 2023, selling an estimated $10M.
  • Sphera Funds Management's ten largest holdings make up 44% of its $598M portfolio in Q1 2023.
  • Sphera Funds Management opened 38 new positions and closed 21 in Q1 2023.
  • Sphera Funds Management's portfolio value rose 28% quarter-over-quarter to $598M.

Based on Sphera Funds Management's 13F filing for Q1 2023, filed 15 May 2023.